11,994
Views
53
CrossRef citations to date
0
Altmetric
LETTERS TO THE EDITOR

Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer

&
Pages 427-428 | Received 07 Sep 2013, Accepted 09 Sep 2013, Published online: 28 Oct 2013

References

  • Stewart DJ, Kurzrock R. Cancer: The road to Amiens. J Clin Oncol 2009;27:328–33.
  • Ashburn TT, Thor KB. Drug repositioning: Identifying and developing new uses for existing drugs. Nature Rev Drug Disc 2004;3:673–83.
  • Mukhopadhyay T, Sasaki J, Ramesh R, Roth JA. Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo. Clin Cancer Res 2002;8:2963–9.
  • Dobrosotskaya IY, Hammer GD, Schteingart DE, Maturen KE, Worden FP. Mebendazole montherapy and long-term disease control in metastatic adrenocortical carcinoma. Endocrine Practice 2011;17:e59–62.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.